Gordon Naylor
Follow
Get notifications in MyBN when activity occurs.
Gordon Naylor
Non-Executive Director, Non-Executive Chairman / Medical Developments International
Most Notable Role
Gordon Naylor has an international business career experience spanning numerous senior operations and corporate roles. He also has experience in advanced manufacturing, business acquisition and restructure.
For over 30 years Mr Naylor was a part of the internationalisation of the CSL Group, a global specialty biotechnology company that was established in Australia. He held a range of business and functional leadership roles including as chief financial officer. At the time of his retirement from CSL, he was the president of Seqirus where he led the 3-year turnaround of that business into one of the vaccine companies in the world.
Mr Naylor holds a Bachelor of Engineering (Honours), a Graduate Diploma in Computer Science, an MBA, and is a graduate of the Australian Institute of Company Directors.
For over 30 years Mr Naylor was a part of the internationalisation of the CSL Group, a global specialty biotechnology company that was established in Australia. He held a range of business and functional leadership roles including as chief financial officer. At the time of his retirement from CSL, he was the president of Seqirus where he led the 3-year turnaround of that business into one of the vaccine companies in the world.
Mr Naylor holds a Bachelor of Engineering (Honours), a Graduate Diploma in Computer Science, an MBA, and is a graduate of the Australian Institute of Company Directors.
Lists and Charts
Total Shareholder Return as at 31/10/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1410th | Medical Developments International | -40% | -39% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Medical Developments International | $33.1m |
1334 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
| NEW ROLE: Non-Executive Director, Orica | 13 Apr 2022 |
| NEW ROLE: Non-Executive Director, Non-Executive Chairman, Medical Developments International | 03 Nov 2020 |
